Non-platinum complexes containing releasable biologically active ligands

P Štarha, Z Trávníček - Coordination Chemistry Reviews, 2019 - Elsevier
Since the discovery of anticancer activity of cisplatin and other transition metal complexes, a
lot of compounds have been reported as containing ligand (s) bearing its (their) own …

Platinum (IV) and platinum (II) anticancer complexes with biologically active releasable ligands

P Štarha, R Křikavová - Coordination Chemistry Reviews, 2024 - Elsevier
The concept of multi-action octahedral platinum (IV) complexes is based on the rational
derivatization of anticancer square-planar platinum (II) compounds (eg, cisplatin or …

Functionalization of platinum complexes for biomedical applications

X Wang, X Wang, Z Guo - Accounts of chemical research, 2015 - ACS Publications
Conspectus Platinum-based anticancer drugs are the mainstay of chemotherapy regimens
in clinic. Nevertheless, the efficacy of platinum drugs is badly affected by serious systemic …

Recent developments on other platinum metal complexes as target-specific anticancer therapeutics

TS Prathima, B Choudhury, MG Ahmad… - Coordination Chemistry …, 2023 - Elsevier
Numerous biologically active metal complexes are reported for their unique features and
enhanced functions, particularly towards the inhibition of cancer progression. With the …

An overview of advancement of organoruthenium (II) complexes as prospective anticancer agents

M Bashir, IA Mantoo, F Arjmand, S Tabassum… - Coordination Chemistry …, 2023 - Elsevier
The successful clinical translation of platinum drugs for cancer treatment has witnessed an
upsurge in the development of metal compounds as therapeutics and diagnostics drugs …

Latest developments in metal complexes as anticancer agents

R Paprocka, M Wiese-Szadkowska… - Coordination Chemistry …, 2022 - Elsevier
Every year novel biologically active compounds are designed as antitumor agents. This
review covers and highlights some of the most important findings described during 2018 …

[HTML][HTML] The challenging treatment of cisplatin-resistant tumors: State of the art and future perspectives

G Coffetti, M Moraschi, G Facchetti, I Rimoldi - Molecules, 2023 - mdpi.com
One of the main problems in chemotherapy using platinum drugs as anticancer agents is the
resistance phenomenon. Synthesizing and evaluating valid alternative compounds is …

The development of anticancer ruthenium (II) complexes: from single molecule compounds to nanomaterials

L Zeng, P Gupta, Y Chen, E Wang, L Ji… - Chemical Society …, 2017 - pubs.rsc.org
Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer
drugs are organic molecules, while metallodrugs are very scarce. The advent of the first …

Metallotherapeutic complexes with high selective properties for anti-neoplastic therapy

S De, S Kazi, S Banerjee, S Banerjee, N Sarkar… - Coordination Chemistry …, 2024 - Elsevier
It is one of the challenging works to deal with second major cause of death due to cancer
and to reduce the mortality rate caused by this. Researchers have been finding various …

Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in the tumor tissue

MS Galanski, BK Keppler - Anti-Cancer Agents in Medicinal …, 2007 - ingentaconnect.com
Cisplatin, carboplatin and oxaliplatin are anticancer drugs, which are efficiently used in the
clinics all over the world. Besides a remarkable therapeutic efficacy in a series of solid …